More articles from Emerging Therapies: Drugs and Regimens

You have access
No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes
Natasha C. Bergmann, Lærke S. Gasbjerg, Sebastian M. Heimbürger, Liva S.L. Krogh, Flemming Dela, Bolette Hartmann, Jens J. Holst, Lene Jessen, Mikkel B. Christensen, Tina Vilsbøll, Asger Lund, Filip K. Knop

Diabetes Care Mar 2020, 43 (3) 588-596; DOI: 10.2337/dc19-0578
You have access
Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study
Jeremy H. Pettus, David D’Alessio, Juan P. Frias, Eric G. Vajda, James D. Pipkin, Julio Rosenstock, Gretchen Williamson, Miriam A. Zangmeister, Lin Zhi, Keith B. Marschke

Diabetes Care Jan 2020, 43 (1) 161-168; DOI: 10.2337/dc19-1328
Open Access
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
Bernard Zinman, Vanita R. Aroda, John B. Buse, Bertrand Cariou, Stewart B. Harris, Søren Tetens Hoff, Karen Boje Pedersen, Mads Jeppe Tarp-Johansen, Eiichi Araki

Diabetes Care Dec 2019, 42 (12) 2262-2271; DOI: 10.2337/dc19-0898
Open Access
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Helena W. Rodbard, Julio Rosenstock, Luis H. Canani, Chaicharn Deerochanawong, Janusz Gumprecht, Søren Østergaard Lindberg, Ildiko Lingvay, Anette Luther Søndergaard, Marianne Bach Treppendahl, Eduard Montanya

Diabetes Care Dec 2019, 42 (12) 2272-2281; DOI: 10.2337/dc19-0883
You have access
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial
Lawrence Blonde, Julio Rosenstock, Stefano Del Prato, Robert Henry, Naim Shehadeh, Juan Frias, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Vanita R. Aroda

Diabetes Care Nov 2019, 42 (11) 2108-2116; DOI: 10.2337/dc19-1357
Open Access
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Deborah J. Wexler, Heidi Krause-Steinrauf, Jill P. Crandall, Hermes J. Florez, Sophia H. Hox, Alexander Kuhn, Ajay Sood, Chantal Underkofler, Vanita R. Aroda, the GRADE Research Group

Diabetes Care Nov 2019, 42 (11) 2098-2107; DOI: 10.2337/dc19-0901
Open Access
The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
Daniël H. van Raalte, Petter Bjornstad, Frederik Persson, David R. Powell, Rita de Cassia Castro, Ping Stella Wang, Minzhi Liu, Hiddo J.L. Heerspink, David Cherney

Diabetes Care Oct 2019, 42 (10) 1921-1929; DOI: 10.2337/dc19-0937
You have access
Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
Geert Jan Biessels, Chloë Verhagen, Jolien Janssen, Esther van den Berg, Bernard Zinman, Julio Rosenstock, Jyothis T. George, Anna Passera, Sven Schnaidt, Odd Erik Johansen

Diabetes Care Oct 2019, 42 (10) 1930-1938; DOI: 10.2337/dc19-0783
You have access
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
Michael A. Nauck, Marie Louise Muus Ghorbani, Eskil Kreiner, Hans A. Saevereid, John B. Buse, the LEADER Publication Committee on behalf of the LEADER Trial Investigators

Diabetes Care Oct 2019, 42 (10) 1912-1920; DOI: 10.2337/dc19-0415
You have access
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
Vanita R. Aroda, Julio Rosenstock, Yasuo Terauchi, Yuksel Altuntas, Nebojsa M. Lalic, Enrique C. Morales Villegas, Ole K. Jeppesen, Erik Christiansen, Christin L. Hertz, Martin Haluzík

Diabetes Care Sep 2019, 42 (9) 1724-1732; DOI: 10.2337/dc19-0749

Main menu

User menu

Search

More articles from Emerging Therapies: Drugs and Regimens

Pages

Navigate

More Information

Other ADA Resources